They reduce de novo lipogenesis by inhibiting transcription factor sterol regulatory element-binding protein 1c (SREBP-1c), which is a master regulator of fatty acid synthesis (Shantaram et al., 2025
Glucagon-Like Peptide-1 receptor agonists and prevention of stroke systematic review of cardiovascular outcome trials with meta-analysis
The most common are gastrointestinal: nausea, vomiting, diarrhea, and constipation
Are not seeking aggressive appetite suppression
Reflecting on the trial Mojsov remembers the therapeutic effect was immediately evident
394 Surprisingly, GLP-1RAs can influence the phospholipid structure and cytokines surrounding joints, leading to beneficial transformations that safeguard joints and even facilitate partial repair of any existing damage